FDA Clearance Tracker · P950027
HYALGAN(R)
Last checked: Nov 19, 2026Latest source record: May 28, 1997 (this decision)Source: openFDAMethods & limitations
Decided
May 28, 1997
Approved
Time to decision
670 days
Received Jul 28, 1995. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P950027
- Device name
- HYALGAN(R)
- Applicant
- Fidia Farmaceutici S.P.A.
- Applicant location
- Abano Terme
- Received
- Jul 28, 1995
- Decided
- May 28, 1997
- Decision
- Approved
- Supplements
- 15 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Acid, hyaluronic, intraarticular (MOZ)
- Device class
- Class III
- Specialty
- Orthopedic Surgery
FDA's approval statement
As written in FDA's record.
THE DEVICE IS INDICATED FOR THE TREATMENT OF PAIN IN OSTEOARTHRITIS (OA) OF THEKNEE IN PATIENTS WHO HAVE FAILED TO RESPOND ADEQUATELY TO CONSERVATIVE NONPHARMACOLOGIC THERAPY, AND TO SIMPLE ANALGESICS, E.G., ACETAMINOPHEN
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code MOZ (Acid, hyaluronic, intraarticular).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Fidia Farmaceutici S.P.A.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K191052 · Decided Jan 9, 2020 · 265 days after receipt
Device type: Lubricant, Personal (NUC) · Obstetrics & Gynecology
- TRILURONPMA
P180040 · Decided Mar 26, 2019 · 180 days after receipt
Device type: Acid, hyaluronic, intraarticular (MOZ) · Orthopedic Surgery
K150883 · Decided Sep 1, 2015 · 152 days after receipt
Device type: Lubricant, Personal (NUC) · Obstetrics & Gynecology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.